In conclusion, our observations indicate that in AKT/YapS127A mice, PD901 but not MLN0128 treatment is able to modulate tumor microenvironment though remodeling CAFs and vasculature, leading to decreased hypoxia. The gene discussed is AKT1; the disease is neoplasm.